Pomegranate Juice May do Wonders for Dialysis Patients
A study presented at the American Society of Nephrology's 43rd Annual Meeting and Scientific Exposition in Denver, CO shows that pomegranate juice may reduce complications for patients with kidney dialysis. The exposition took place the week of November 16, 2010.
Researchers from the Western Galilee Hospital in Israel recruited 101 dialysis patients for the study. The participants received either pomegranate juice or a placebo at the beginning of each dialysis session three times a week for one year.
They found that drinking pomegranate juice for 12 months provided a “continuous, accumulative, beneficial effect for dialysis patients.”
The benefits included a reduction in inflammation, oxidative stress and blood lipid profiles. They also found that pomegranate juice reduced the risk of hospitalization, with a 40% reduction in first hospitalization events, and an 80% decrease in secondary hospitalizations.
On top of that, they also found that pomegranate juice may provide significant improvements in cardiovascular risk factors such as blood pressure and cardiovascular events.
When the researchers had the patients stop drinking pomegranate juice for 3 months, all of the beneficial effects quickly dissipated.
This study adds to the science backing the potential benefits of this increasingly popular drink. Pomegranates are very high in antioxidants (3x more per ounce than green tea or wine) and protective vitamins, and ongoing research is verifying its ability to reduce the risk of prostate cancer, improve heart health, reduce cholesterol and reduce joint pain.